Working… Menu

Chinese Community Smoking Cessation Project

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00139516
Recruitment Status : Completed
First Posted : August 31, 2005
Last Update Posted : March 13, 2014
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
University of California, San Francisco

Brief Summary:

The study has two objectives/aims:

Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and

Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months

Condition or disease Intervention/treatment Phase
Cardiovascular Diseases Heart Diseases Lung Diseases Diabetes Mellitus Chronic Obstructive Pulmonary Disease Behavioral: self-help Drug: nicotine replacement therapy Behavioral: smoking cessation Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Primary Purpose: Prevention
Study Start Date : September 2001
Actual Primary Completion Date : August 2007
Actual Study Completion Date : August 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Quitting Smoking

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • having smoked a cigarette, cigar, or tobacco pipe during the 3 months preceding the baseline interview
  • reside in the San Francisco Bay Area at baseline
  • must be fluent in either English or Chinese (Mandarin or Cantonese)
  • be 18 and over in age and
  • not currently engaging in assisted smoking cessation efforts

Exclusion criteria

  • unable to speak English or Chinese
  • too ill to participate, or not willing to participate in smoking cessation effort
  • pregnancy
  • major psychiatric illness not under control/treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00139516

Sponsors and Collaborators
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
Layout table for investigator information
OverallOfficial: Candice Wong University of California at San Francisco
Layout table for additonal information Identifier: NCT00139516    
Other Study ID Numbers: 247
R01HL069363 ( U.S. NIH Grant/Contract )
First Posted: August 31, 2005    Key Record Dates
Last Update Posted: March 13, 2014
Last Verified: March 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Cardiovascular Diseases
Heart Diseases
Respiratory Tract Diseases
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action